Study title: Tolerance of olsalazine in young patients treated for ulcerative colitis
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Digestive System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: OLSALAZINE | |||||
ATC code: A07EC03 | |||||
Document link: L342G26R1 - Olsalazine sodium.pdf | |||||
Document date: 2011-11-28 | |||||
Study number: L342G26R1 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |